QUEST DIAGNOSTICS TO SPEAK AT THE 40TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

Rhea-AI Summary

Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, will present at the 40th Annual J.P. Morgan Healthcare Conference. Steve Rusckowski, Chairman and CEO, is set to discuss the company's vision and capital strategies on January 12, 2022, at 9:00 a.m. ET. The live presentation will be webcast and later archived on the company's investor relations page, accessible until February 11, 2022. Quest Diagnostics serves one in three adults in the U.S. and employs nearly 50,000 staff, focusing on improving health outcomes through diagnostic insights.

SECAUCUS, N.J., Jan. 4, 2022 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the 40^th Annual J.P. Morgan Healthcare Conference. Steve Rusckowski, Chairman, CEO and President, will discuss the company's vision, goals, and capital deployment strategies.  The virtual presentation is scheduled for Wednesday, January 12, 2022, at 9:00 a.m. Eastern Time.

The presentation and Q&A session will be webcast live during the conference and will be available on the company's investor relations page which can be accessed at ir.QuestDiagnostics.com.  In addition, the archived webcast will be available within 24 hours after the conclusion of the live event and will remain available until February 11, 2022.

About Quest Diagnostics
Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our nearly 50,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. www.QuestDiagnostics.com.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/quest-diagnostics-to-speak-at-the-40th-annual-jp-morgan-healthcare-conference-301453889.html

SOURCE Quest Diagnostics

FAQ

When will Quest Diagnostics present at the J.P. Morgan Healthcare Conference?

Quest Diagnostics is scheduled to present on January 12, 2022, at 9:00 a.m. Eastern Time.

Who will represent Quest Diagnostics at the conference?

Steve Rusckowski, Chairman and CEO, will represent Quest Diagnostics at the conference.

How can I access Quest Diagnostics' presentation at the J.P. Morgan Healthcare Conference?

The presentation will be webcast live and can be accessed via Quest Diagnostics' investor relations page.

How long will the archived presentation of Quest Diagnostics be available?

The archived presentation will be available until February 11, 2022.

What is the focus of Quest Diagnostics' presentation at the conference?

The focus will be on the company's vision, goals, and capital deployment strategies.